Your browser doesn't support javascript.
Corrigendum to: Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) [Pharmacol. Res. 156 (2020) 104761].
Runfeng, Li; Yunlong, Hou; Jicheng, Huang; Weiqi, Pan; Qinhai, Ma; Yongxia, Shi; Chufang, Li; Jin, Zhao; Zhenhua, Jia; Haiming, Jiang; Kui, Zheng; Shuxiang, Huang; Jun, Dai; Xiaobo, Li; Xiaotao, Hou; Lin, Wang; Nanshan, Zhong; Zifeng, Yang.
  • Runfeng L; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China.
  • Yunlong H; Hebei University of Chinese Medicine, College of Integrated Chinese and Western Medicine, China.
  • Jicheng H; Technology Centre, Guangzhou Customs, China.
  • Weiqi P; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China.
  • Qinhai M; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China.
  • Yongxia S; Technology Centre, Guangzhou Customs, China.
  • Chufang L; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China.
  • Jin Z; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China.
  • Zhenhua J; Hebei University of Chinese Medicine, College of Integrated Chinese and Western Medicine, China.
  • Haiming J; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China.
  • Kui Z; Technology Centre, Guangzhou Customs, China.
  • Shuxiang H; Technology Centre, Guangzhou Customs, China.
  • Jun D; Technology Centre, Guangzhou Customs, China.
  • Xiaobo L; Technology Centre, Guangzhou Customs, China.
  • Xiaotao H; KingMed Virology Diagnostic & Translational Center, China.
  • Lin W; KingMed Virology Diagnostic & Translational Center, China.
  • Nanshan Z; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China.
  • Zifeng Y; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China; State Key Laboratory of Quality Research in Chinese Medici
Pharmacol Res ; 174: 105907, 2021 Dec.
Article in English | MEDLINE | ID: covidwho-1778406
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Pharmacol Res Journal subject: Pharmacology Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Pharmacol Res Journal subject: Pharmacology Year: 2021 Document Type: Article